Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,252.83
    +4.34 (+0.08%)
     
  • Dow

    39,773.93
    +13.85 (+0.03%)
     
  • Nasdaq

    16,394.37
    -5.15 (-0.03%)
     
  • Bitcoin USD

    71,123.29
    +1,824.00 (+2.63%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,967.95
    +35.97 (+0.45%)
     
  • Gold

    2,234.80
    +22.10 (+1.00%)
     
  • Crude Oil

    82.52
    +1.17 (+1.44%)
     
  • 10-Yr Bond

    4.1910
    -0.0050 (-0.12%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Intercept: 2Q Earnings Snapshot

Intercept: 2Q Earnings Snapshot

NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Thursday reported a loss of $75.9 million in its second quarter.

The New York-based company said it had a loss of $2.58 per share.

The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $2.83 per share.

The drugmaker posted revenue of $43.6 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $39.9 million.

Intercept shares have climbed 57 percent since the beginning of the year. The stock has declined 17 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ICPT at https://www.zacks.com/ap/ICPT